Manufacturer of Controlled Substances; Notice of Application, 33316 [E6-8915]
Download as PDF
33316
Federal Register / Vol. 71, No. 110 / Thursday, June 8, 2006 / Notices
the basic class of controlled substance
listed in Schedule II:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug
Manufacturer of Controlled
Substances; Notice of Application
Schedule
Cocaine (9041) .............................
II
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on December
5, 2005, Organix Inc., 240 Salem Street,
Woburn, Massachusetts 01801, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Cocaine (9041), a basic class of
controlled substance listed in Schedule
II.
The company plans to manufacture a
chemical that is a derivative of cocaine
that will be sold to another company for
research purposes.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than August 7, 2006.
The company plans to import small
quantities of the listed controlled
substance for the National Institute of
Drug Abuse and other clients.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Research Triangle Institute to import the
basic class of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Research Triangle Institute to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substances
listed.
Dated: June 1, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–8915 Filed 6–7–06; 8:45 am]
BILLING CODE 4410–09–P
Dated: June 1, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–8914 Filed 6–7–06; 8:45 am]
DEPARTMENT OF LABOR
Employment and Training
Administration
BILLING CODE 4410–09–P
[TA–W–58,893; TA–W–58,893Z]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
cprice-sewell on PROD1PC66 with NOTICES
Importer of Controlled Substances;
Notice of Registration
By Notice dated August 11, 2005 and
published in the Federal Register on
August 19, 2005, (70 FR 48779–48780),
Research Triangle Institute, Kenneth H.
Davis Jr., Hermann Building East
Institute Drive, P.O. Box 12194,
Research Triangle Park, North Carolina
27709, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
VerDate Aug<31>2005
15:37 Jun 07, 2006
Jkt 208001
Agilent Technologies, Inc.; Automated
Test Group; Semiconductor Test
Solutions Including On-Site Leased
Workers of Voit; Santa Rosa, CA;
Including an Employee of Agilent
Technologies, Inc.; Automated Test
Group, Semiconductor Test Solutions,
Santa Rosa, CA; Located in Portland,
OR; Amended Certification Regarding
Eligibility To Apply for Worker
Adjustment Assistance and Alternative
Trade Adjustment Assistance
In accordance with section 223 of the
Trade Act of 1974 (19 U.S.C. 2273), and
section 246 of the Trade Act of 1974 (26
U.S.C. 2813), as amended, the
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Department of Labor issued a
Certification Regarding Eligibility to
Apply for Worker Adjustment
Assistance and Alternative Trade
Adjustment Assistance on March 29,
2006, applicable to workers of Agilent
Technologies, Inc., Automated Test
Group, Semiconductor Test Solutions,
including on-site leased workers of Voit,
Santa Rosa, California. The notice was
published in the Federal Register on
April 17, 2006 (71 FR 19753).
At the request of a company official,
the Department reviewed the
certification for workers of the subject
firm.
New information shows that a worker
separation has occurred involving an
employee of the Santa Rosa, California
facility of Agilent Technologies, Inc.,
Automated Test Group, Semiconductor
Test Solutions located in Portland,
Oregon. Ms. Jane Parker provided sales
support services for the production of
Radio Frequency (RF) Content for the
Agilent 93000 Tester at the Santa Rosa,
California location of the subject firm.
Based on these findings, the
Department is amending this
certification to include an employee of
the Santa Rosa, California facility of the
subject firm located in Portland, Oregon.
The intent of the Department’s
certification is to include all workers of
the Santa Rosa, California location of
the subject firm who were adversely
affected by increased company imports.
The amended notice applicable to
TA–W–58,893 is hereby issued as
follows:
‘‘All workers of Agilent Technologies, Inc.,
Automated Test Group, Semiconductor Test
Solutions, including on-site leased workers
of Voit, Santa Rosa, California (TA–W–
58,893) including an employee of Agilent
Technologies, Inc., Automated Test Group,
Semiconductor Test Solutions, Santa Rosa,
California located in Portland, Oregon (TA–
W–58,893Z, who became totally or partially
separated from employment on or after
February 22, 2005 through March 29, 2008,
are eligible to apply for adjustment assistance
under Section 223 of the Trade Act of 1974
and are also eligible to apply for alternative
trade adjustment assistance under Section
246 of the Trade Act of 1974.’’
Signed at Washington, DC, this 19th day of
May 2006.
Elliott S. Kushner,
Certifying Officer, Division of Trade
Adjustment Assistance.
[FR Doc. E6–8943 Filed 6–7–06; 8:45 am]
BILLING CODE 4510–30–P
E:\FR\FM\08JNN1.SGM
08JNN1
Agencies
[Federal Register Volume 71, Number 110 (Thursday, June 8, 2006)]
[Notices]
[Page 33316]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-8915]
[[Page 33316]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on December 5, 2005, Organix
Inc., 240 Salem Street, Woburn, Massachusetts 01801, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of Cocaine (9041), a basic class of
controlled substance listed in Schedule II.
The company plans to manufacture a chemical that is a derivative of
cocaine that will be sold to another company for research purposes.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than August 7, 2006.
Dated: June 1, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-8915 Filed 6-7-06; 8:45 am]
BILLING CODE 4410-09-P